Live Breaking News & Updates on Nerve cells

Stay informed with the latest breaking news from Nerve cells on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nerve cells and stay connected to the pulse of your community

FOX and Friends

ingredients that you need to know about. >> lawrence: carley shimkus. >> carley: bills are advancing in multiple states which could ban thousands of your favorite snacks. new york, illinois and pennsylvania are introducing measuring to ban 13 additives over suspected health risks. new jersey and missouri are considering this, too. the snacks that could be on the chong block include lucky charms oreos, gator aid and flaming hot cheetos there are concerns that the food dies in these products may cause health problems. lucky charms contains the yellow 6 additive that some say is linked to adrenal tumors. flaming hot cheetos yellow 5 and yellow 6 which studies show it can cause d.n.a. mutations in white blood cells. oreo contain blue 1 with concerns that it could potentially cause kidney tumors and damaged nerve cells. and the food dye gatorade cancer

Lawrence , Snacks , States , New-york-city , Pennsylvania , Bills , Ingredients , Carley-shimkus , Thousands , Additives , Illinois , 13

Are Spinal Injuries Irreversible? Expert Reveals the Truth |

Learn about spinal injuries and their reversibility. Discover the latest scientific advances and treatments for spinal cord injuries. Find out what experts have to say.

Arun-bhanot , Spinal-injuries , Sensory-deficits , Paralysis , Nerve-cells , Irreversible ,

How to restore nerve cells after injury: Research

The study shows a way to repair destroyed nerves during peripheral neuropathy, opening up possibilities for new therapeutics to increase repair function. | Health

United-states , Benjaminh-lewis , Lydia-daboussi , Samuel-pfaff , Los-angeles , Research-shutterstock , Cell-reports , Professor-samuel , Charcot-marie-tooth , Nerve-cells , Nerve-cells-repair , Nerve-cells-after-injury

Neurotransmitter Ballet: NMDA and AMPA in MDD Management

Experts highlight the role of NMDA and AMPA receptors in major depressive disorder (MDD) and how new therapies are targeting novel mechanisms of action.

Craig-chepke , Greg-mattingly , Gus-alva , Serotonin , Norepinephrine , Ion-channels , Glutamate , Gaba , Calcium , Nerve-cells , Chloride

Cognitive Wellness: The Potential of Glutamate Modulation for MDD

Clinicians discuss the effects of glutamate modulation on neuroplasticity, memory, and cognitive function, highlighting their role in improving overall wellness for their patients.

Rapid-acting-therapies , Glutamate-modulation , Serotonin , Norepinephrine , Ion-channels , Glutamate , Gaba , Calcuim , Nerve-cells , Hippocamps , Cognition

spinal cord: Direction of nerve cells is critical for restoring spinal cord after injury, says study

Scientists at the University of California - Los Angeles (UCLA) have found that directing and nudging nerve cells is crucial for restoring the ability to walk in mice with spinal cord injuries.

California , United-states , Los-angeles , Michael-sofroniew , University-of-california , Spinal-cord , Nerve-cells , Spinal-cord-injury , Neuroscience , Restore-walking ,

CBS Evening News With Norah ODonnell

defense secretary emma senator agree on one thing. but if tuberville continues his hold on military promotions, there could be a backlog of 658 generals and admirals by the end of the year. norah? >> norah: not to mention the effect on military families. david martin with that important story. thank you. while now to our continuing series, "the age of ai." about 5,000 people a year in the u.s. are diagnosed with als. that is also known as lou gehrig's disease, and the deadly disease affects the nerve cells in the brain and spinal cord, causing patients to lose their ability to move and speak. cbs's chief medical correspondent dr. jon lapook shows us how artificial intelligence is helping patients preserve their voices. >> hi, my name is ryan, and this is my story living with als. >> reporter: 46-year-old brian jeansonne talks to the world about his journey with als, through tiktoks, making the videos with his family and caregivers, he began

Biofrereeze-norah , Norah , Hold , Defense-secretary , Generals , Thing , Backlog , Military-promotions , The-end , 658 , One , People

CBS Evening News With Norah ODonnell

>> lecanemab is the first consistently effective disease modifying therapy for alzheimer's. i think that qualifies it as a game changer. >> reporter: in all thymus patients, amyloid proteins form plaques in the brain which interrupt normal communication between nerve cells, leading to cognitive decline. lecanemab is an antibody that removes existing plaques and prevents new ones from forming. does this new drug actually delay the decline in cognitive function? >> it slows the declined by about 27%. >> reporter: what does that translate into months? >> about six months. >> reporter: the benefit was seen over a trial with alzheimer's patients. >> births, deaths, weddings. >> reporter: lecanemab is given intravenously come across more than $26,000 a year, and will be covered by medicare. researchers say it is not a cure and cannot restore memories. still, for patients like

Reporter , Disease , Alzheimer-s , Patients , Brain , Amyloid-proteins , Lecanemab , Plaques , Game-changer , Communication , Therapy , Drug

Neurons linked to chronic stress: Research

The study explores how neurons play a role in developing unpleasant emotions and stress in the brain. | Health

Sweden , Pierre-le-merre , Marie-carlen , Karolinska-institutet , Konstantinos-meletis , Janos-fuzik , Daniela-calvigioni , Department-of-neuroscience , Professor-meletis , Neuron , Neurons , Nerve-cells

New Promising Drug for Cancer That Develops From Immature Nerve Cells

Clinically resistant Neuroblastomas with anaplastic lymphoma kinase (ALK) aberrations seems to be sensitive pre-clinically to the third-generation ALK inhibitor lorlatinib.

Children-oncology-group , Oncology-group , Neuroblastoma , Anticancer-drugs , Anaplastic-lymphoma-kinase-alk-aberrations , Nerve-cells , Childhood-cancer ,